East Coast Institute for Research

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• Coronary artery disease1 trial
• Obesity1 trial
• Type 1 diabetes1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed3 trials
• Recruiting2 trials

Lead sponsor

• Amgen2 trials
• Diasome Pharmaceuticals1 trial
• Insulet Corporation1 trial
• Medtronic MiniMed, Inc.1 trial

Running trials

• Recruiting

  Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  NCT07575399· Phase 3· Amgen· Source

• Recruiting

  OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  NCT07136012· Phase 3· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting
• Obesity1 recruiting

Closed trials

• Completed

  Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

  NCT06238778· Phase 2· Diasome Pharmaceuticals· Source

• Completed

  OP5-005 Using Omnipod 5 in Adults With Type 2

  NCT05815342· Insulet Corporation· Source

• Completed

  In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes

  NCT05238142· Medtronic MiniMed, Inc.· Source